CellSource Co., Ltd.
Notice Regarding Expected Recognition of Inventory Valuation Loss and Extraordinary Loss
Announced expected recognition of inventory valuation loss of 46 million yen and impairment loss on fixed assets of 11 million yen. These are within the scope of the earnings guidance, and no revision to the guidance will be made at this time.
Key Figures
- Inventory valuation loss: 46 million yen
- Extraordinary loss (impairment): 11 million yen
- Total impact amount: 58 million yen
AI要約
Key Points of the News
The Company announced that for the fiscal year ending October 2026, it expects to record an inventory valuation loss of 46 million yen related to the Consumer Business and an impairment loss on fixed assets of 11 million yen. The total impact is assumed to be 58 million yen, and the current earnings guidance remains unchanged.
Future Actions and Impact
If the above losses become additional disclosure items, the Company will promptly disclose them. At present, the Company states that developments are within the scope of the earnings guidance announced on September 8, 2026, and no short-term revisions to the guidance will be made.
CellSource Co., Ltd.
Company overview · Stock price · Financial data · All IR
